Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Clinical Chemistry|August 1, 1991
Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formulaM Sentí, J Pedro-Botet, X Nogués, et al.Scandinavian Journal of Clinical and Laboratory Investigation|July 1, 1996
Interrelationship of triglyceride-rich lipoproteins, serum lipoprotein (a) concentration and apolipoprotein(a) sizeM Sentí, J Pedro-Botet, J Rubiés-Prat, et al.Angiology|March 1, 1996
Secondary prevention of coronary heart disease in patients with extracoronary atherosclerosis: a need for accuracy of low density lipoprotein determinationM Sentí, J Pedro-Botet, J Rubiés-Prat, et al.Medicina Clinica|April 6, 1991
[Changes in high density lipoproteins in peripheral vascular disease]J Pedro-Botet, M Sentí, X Nogués, et al.Circulation|January 1, 1992
Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypesM Sentí, X Nogués, J Pedro-Botet, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Effect of bezafibrate on lipoprotein (a) and triglyceride-rich lipoproteins, including intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysisA Pelegrí, R Romero, M Sentí, et al.Kidney International|May 1, 1992
Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failureM Sentí, R Romero, J Pedro-Botet, et al.Angiology|August 1, 1991
Serum lipoprotein (a) levels in men with peripheral vascular diseaseX Nogués, M Sentí, J Pedro-Botet, et al.Stroke|November 1, 1992
Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphismJ Pedro-Botet, M Sentí, X Nogués, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphismT Auguet, M Sentí, J Rubiés-Prat, et al.Pageof 9